The C.D.C. recommends that other vaccines be preferred over J.&J.

The agency’s advisers cited concerns about the increased incidence of a rare but potentially serious blood clotting condition among those who received the company’s shot.

from NYT > Health https://ift.tt/32ehXoa
via health&fitness